| Authors: |
Wood WA; Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC., Marks P; U.S. Food and Drug Administration, Silver Spring, MD., Plovnick RM; The American Society of Hematology, Washington, DC., Hewitt K; ASH Research Collaborative, Washington, DC., Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Walters S; Breakthrough Healthcare, Baltimore, MD., Dolan BK; The University of Wisconsin School of Medicine and Public Health, Madison, WI., Tucker EA; ASH Research Collaborative, Washington, DC., Abrams CS; Department of Medicine, University of Pennsylvania, Philadelphia, PA., Thompson AA; Department of Pediatrics, Northwestern University, Chicago, IL; and., Anderson KC; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA., Kluetz P; U.S. Food and Drug Administration, Silver Spring, MD., Farrell A; U.S. Food and Drug Administration, Silver Spring, MD., Rivera D; U.S. Food and Drug Administration, Silver Spring, MD., Gertzog M; The American Society of Hematology, Washington, DC., Pappas G; U.S. Food and Drug Administration, Silver Spring, MD. |
